Lipid peroxidation is not increased in patients with untreated mild-to-moderate hypertension

Hypertension

Volumn 41, Issue 2, 2003, Pages 286-288

  Cracowski, Jean Luc ^a   Baguet, Jean Philippe ^a   Ormezzano, Olivier ^a   Bessard, Janine ^a   Stanke Labesque, Françoise ^a   Bessard, Germain ^a   Mallion, Jean Michel ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

Blood pressure monitoring, ambulatory; Essential; Hypertension; Lipid peroxidation; Oxidative stress; Prostaglandins

Indexed keywords

ARACHIDONIC ACID; GLUCOSE; ISOPROSTANE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROSTAGLANDIN;

ADULT; AGE; ARTICLE; BLOOD PRESSURE MONITORING; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GAS CHROMATOGRAPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INTIMA; LIPID PEROXIDATION; MALE; MASS SPECTROMETRY; OXIDATIVE STRESS; PRIORITY JOURNAL; PULSE PRESSURE; PULSE WAVE; TUNICA MEDIA; URINE LEVEL;

BLOOD PRESSURE; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DINOPROST; F2-ISOPROSTANES; FEMALE; HUMANS; HYPERTENSION; LIPID PEROXIDATION; MALE; MIDDLE AGED; SINGLE-BLIND METHOD;

EID: 0037317784     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000050963.16405.E6     Document Type: Article

References (15)

1. Berry C, Brosnan MJ, Fennell J, Hamilton CA, Dominiczak AF. Oxidative stress and vascular damage in hypertension. Curr Opin Nephrol Hypertens. 2001;10:247-255.
2. Zalba G, San Jose G, Moreno MU, Fortuno MA, Fortuno A, Beaumont FJ, Diez J. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension. 2001;38:1395-1399.
3. Wu L, Juurlink BH. Increased methylglyoxal and oxidative stress in hypertensive rat vascular smooth muscle cells. Hypertension. 2002;39:809-814.
4. Moore K, Roberts LJ 2nd. Measurement of lipid peroxidation. Free Rad Res. 1998;28:659-671.
5. 2-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med. 2000;28:505-513.
6. Cracowski JL, Durand T, Bessard G. Isoprostanes as a biomarker of lipid peroxidation in humans: physiology, pharmacology and clinical implications. Trends Pharmacol Sci. 2002;23:360-366.
7. 2-isoprostanes) in smokers. N Engl J Med. 1995;332:1198-1203.
8. 2 isoprostanes in hypercholesterolemia. Circulation. 1998;98:2822-2828.
9. 2α and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. Circulation. 1999;99:224-229.
10. Baguet JP, Mallion JM, Moreau-Gaudry A, Noirclerc M, Peoc'h M, Siche JP. Relationships between cardiovascular remodelling and the pulse pressure in never treated hypertension. J Hum Hypertens. 2000;14:23-30.
11. Baguet JP, Moreau-Gaudry A, Siche JP, Douchin S, Tremel F, Mallion JM. Carotid remodeling in essential hypertension: role of blood pressure, indexed parameters, and association with cardiac mass and aortic stiffness. Clin Exp Hypertens. 2000;22:717-729.
12. 2α type III in human urine by gas chromatography-electronic impact mass spectrometry. Comparison with enzyme immunoassay. J Chromatogr B. 2001;754:333-343.
13. 2α generation during coronary reperfusion. Circulation. 1997;95:2492-2499.
14. 2α in acute coronary angioplasty: evidence for oxidant stress during coronary reperfusion in humans. Circulation. 1997;96:3314-3320.
15. 2-isoprostanes in systemic sclerosis but not in primary Raynaud's phenomenon. Effect of a cold exposure. Arthritis Rheum. 2002;46:1319-1323.